CERo Therapeutics (CERO) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CERO CERo Therapeutics

Watchlist

0.202
+0.055+37.62%

Close Nov 27 16:00 ET

0.194
-0.008-3.95%

Post 19:59 ET

30.41MMarket Cap-54P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Cero Therapeutics Holdings - Potential Offer and Sale of up to 210 Mln Shares by Keystone Capital Partners
ReutersNov 27 06:22 ET
10-Q/A: Quarterly report (Amendment)
SECNov 20 11:40 ET · Announcements
10-Q: Q3 2024 Earnings Report
SECNov 19 17:21 ET · Announcements
12 Health Care Stocks Moving In Friday's Pre-Market Session
BenzingaNov 15 16:06 ET
CERo Therapeutics CERO IND Cleared; TFF Pharmaceutical TFFP Winding Down
BioPharmCatalystNov 15 15:40 ET
Trending Stocks Today | The Arena Group Shoots up 182.45%
Moomoo NewsNov 15 14:00 ET

Comments

This_Guy

14 hours ago

Chart manipulation, what every trader needs to know

Today I was asked how I was able to get in early on some plays this week that gave significant returns. Someone jumped into the comment section and declared it was not possible to know when a stock was going g to run. The person commented because I indicated I saw potential in the stocks running from the activity I observed the day before or days before. Some of them had no news and others had news after I entered and on the day the stock ran.
...

zine1

21 hours ago

$CERo Therapeutics (CERO.US)$ holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding holding

zine1

21 hours ago

$CERo Therapeutics (CERO.US)$ let's fly guys to the moon 🌙 is Thanksgiving 😍 is gift 🎁 let's fly 1$

zine1

21 hours ago

$CERo Therapeutics (CERO.US)$ 1$ guys come on push push higher higher holding holding holding holding holding holding holding holding holding holding holding holding CERo Therapeutics (CERO) shares surged 62%. The US Food and Drug Administration cleared the company's investigational new drug application for a phase 1 trial of its lead compound CER-1236 to treat acute myelogenous leukemia.